7Baggers
Quarterly
Annual
    Unit: USD2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 
      
    		                             
      operating activities:
    		                             
      net income attributable to nextdecade corporation
    		-245,228,000 481,443,000 -393,075,000 2,304,000 186,775,000 -255,848,000 181,844,000 -120,289,000 -27,347,000 -18,925,000 -18,797,000 -10,912,000 -11,437,000 -8,023,000 1,222,000   -2,279,000 -7,178,000 -5,774,000 902,000 -13,881,000 -3,228,000 -6,719,000 -12,043,000     
      adjustment to reconcile net income to net cash from operating activities
    		                             
      depreciation
    		613,000 614,000 613,000 620,000 84,000 51,000 42,000 37,000 38,000 33,000 40,000 42,000 47,000 48,000 43,000 45,000 48,000 50,000 66,000 64,000 16,000 87,000 79,000 44,000 41,000 44,000 50,000 48,000 29,000 
      share-based compensation expense
    		6,602,000 6,075,000 4,985,000 4,408,000 4,439,000 4,498,000 9,715,000 10,781,000 1,559,000 3,917,000 3,040,000 2,887,000 -2,372,000 1,258,000 -2,709,000 867,000 -3,729,000 418,000 837,000 264,000 -1,860,000 2,891,000 -4,720,000 -13,155,000 5,338,000 4,109,000 1,480,000 -983,000 12,234,000 
      derivative gain
    		168,700,000  329,733,000 -109,067,000 -258,872,000                         
      derivative settlements
    		3,932,000 3,445,000 2,728,000 37,598,000 4,905,000                         
      amortization of leases
    		                             
      loss on extinguishment of debt
    		 1,741,000 0 40,133,000 7,440,000                         
      corporate fixed asset retirements
    		3,518,000                             
      amortization of debt issuance costs
    		16,916,000 16,267,000 15,979,000 16,702,000 16,388,000 15,720,000                        
      interest elected to be paid-in-kind
    		                             
      other
    		-158,000 -1,728,000 -1,255,000 3,478,000 98,000                         
      changes in operating assets and liabilities:
    		                             
      prepaid expenses and other current assets
    		-1,149,000 -1,621,000 782,000 1,089,000 -1,104,000 181,000 -1,070,000                       
      accounts payable
    		2,071,000 -5,482,000 950,000 -1,156,000 3,466,000 744,000 3,004,000 -506,000 815,000 390,000 -138,000 318,000 114,000 -102,000 85,000 36,000 -45,000 108,000 -94,000 -356,000 -28,000 123,000 -462,000 272,000 274,000 166,000 16,000 98,000 -156,000 
      operating leases
    		                             
      accrued expenses and other liabilities
    		-25,318,000 35,133,000 -25,973,000 10,711,000 5,384,000 -21,538,000 13,901,000 -1,279,000 1,836,000 3,731,000 2,913,000 2,162,000 -2,994,000 554,000 972,000 1,552,000 1,390,000 -611,000 225,000 -119,000 -5,364,000 1,756,000 754,000 547,000 -1,148,000 -3,859,000 5,238,000 965,000 -1,543,000 
      net cash from operating activities
    		-68,826,000 -8,903,000 -63,844,000 5,987,000 -28,825,000 -20,993,000 -11,423,000 -18,019,000 -23,185,000 -12,115,000 -10,486,000 -7,281,000 -10,194,000 -5,708,000 -4,552,000 -3,910,000 -3,790,000 -3,507,000 -3,964,000 -4,544,000 -14,238,000 -7,417,000 -8,049,000 -17,227,000 -8,007,000 -10,639,000 -3,585,000 -3,264,000 -5,797,000 
      investing activities:
    		                             
      acquisition of property, plant and equipment
    		-769,971,000 -694,607,000 -505,308,000 -577,554,000 -790,332,000 -741,169,000 -943,514,000 -31,425,000 -21,528,000 -28,080,000 -3,071,000 -1,288,000 -1,314,000 -3,715,000 -2,909,000 -3,097,000 -2,384,000 -2,264,000 -1,925,000 -14,337,000 -13,826,000 -1,694,000 -4,532,000 -8,194,000 -5,883,000 -7,198,000 -3,714,000 -2,569,000 -5,177,000 
      acquisition of other non-current assets
    		-9,438,000 0 0 -371,000 -6,033,000 -1,193,000 -10,453,000 -1,643,000 -1,875,000 -1,792,000 -1,735,000 -1,905,000 -1,703,000 -1,763,000 -1,562,000 -1,571,000 -1,533,000 -1,521,000 -1,533,000 -1,750,000 -6,107,000         
      net cash from investing activities
    		-779,409,000 -694,607,000 -505,308,000 -577,925,000 -796,365,000 -742,362,000 -953,967,000 -33,068,000 -23,403,000 -29,872,000 -4,806,000 -3,193,000 -3,017,000 -5,478,000 -4,471,000 -4,668,000 -3,917,000 -3,785,000 -3,458,000 -16,087,000 41,851,000 -30,478,000 7,665,000 -4,558,000 10,678,000 -19,601,000 -58,764,000 -2,595,000 -5,201,000 
      financing activities:
    		                             
      proceeds from debt issuance
    		645,000,000 724,353,000 498,336,000 1,531,673,000 768,881,000 674,000,000                        
      receipt of equity commitments
    		215,000,000 182,667,000 160,000,000 138,706,000 194,627,000                         
      repayment of debt
    		 -56,243,000 0 -1,106,000,000 -176,000,000                         
      costs associated with repayment of debt
    		 0 -3,975,000 -8,453,000 -995,000                         
      debt issuance costs
    		-18,330,000  -16,066,000                           
      shares repurchased related to share-based compensation
    		-49,000 -125,000 -6,424,000 -59,000 -94,000 -20,000 -9,537,000 -23,000 -47,000 -460,000 -1,060,000 -1,288,000 -464,000 -5,000 -139,000 -96,000 -44,000 -24,000 -211,000 -54,000 -57,000 0 -219,000 -171,000 -260,000 -16,000    
      net cash from financing activities
    		841,621,000 830,474,000 631,871,000 523,619,000 782,110,000 611,974,000 1,371,237,000 39,958,000 34,940,000 -4,447,000 84,015,000 28,616,000 10,017,000 -5,000 5,171,000 9,883,000 24,389,000 -33,000 -224,000 -69,000 14,930,000 49,790,000 -318,000 20,759,000 -271,000 -471,000    
      net increase in cash, cash equivalents and restricted cash
    		-6,614,000 126,964,000                            
      cash, cash equivalents and restricted cash – beginning of period
    		392,761,000 0 0 0 294,478,000                         
      cash, cash equivalents and restricted cash – end of period
    		386,147,000 126,964,000 62,719,000 -48,319,000 251,398,000                         
      balance per consolidated balance sheets:
    		                             
      cash and cash equivalents
    		130,938,000 109,907,000 88,000 -7,611,000 45,753,000 -12,606,000                        
      restricted cash
    		255,209,000 17,057,000 62,631,000 -40,708,000 205,645,000 -138,775,000                        
      total cash, cash equivalents and restricted cash
    		386,147,000  62,719,000 -48,319,000 251,398,000 -151,381,000                        
      rio grande lng facility under construction
    		5,696,258,000 692,126,000 596,116,000 570,207,000 3,150,790,000                         
      corporate and other
    		8,163,000 -886,000 91,000 5,826,000 7,711,000                         
      total property, plant and equipment, at cost
    		5,704,421,000 691,240,000 596,207,000 576,033,000 3,158,501,000                         
      less: accumulated depreciation
    		-1,712,000 -613,000 -614,000 -492,000 -259,000                         
      total property, plant and equipment
    		5,702,709,000 690,627,000 595,593,000 575,541,000 3,158,242,000                         
      amortization of right-of-use assets
    		1,087,000 1,086,000 1,086,000 1,249,000 1,324,000 2,410,000 47,000 265,000 258,000 234,000 192,000 190,000 140,000 137,000 133,000 142,000 139,000 246,000 329,000 331,000 324,000         
      operating lease liabilities
    		-412,000 -429,000 -397,000 -566,000 -668,000 -509,000 923,000 -303,000 -290,000 -196,000 -216,000 -110,000 -156,000 -152,000 -89,000 -149,000 -158,000 -164,000 -208,000 -231,000 -271,000 -821,000 -537,000       
      loss on common stock warrant liabilities
    		    1,516,000 -641,000 -3,302,000 5,455,000 367,000 -1,445,000 2,774,000 -1,886,000 6,304,000           1,641,000 197,000     
      derivative (gain) loss
    		                             
      gain on sale of assets
    		     308,000                        
      proceeds from sale of common stock
    		     0 179,400,000 40,000,000 35,000,000 0 85,000,000   168,000                
      debt and equity issuance costs
    		    -4,309,000 -3,310,000                        
      preferred stock dividends
    		     0 -21,000 -19,000 -13,000 -37,000 1,000 -20,000 -19,000 -17,000 -23,000 -14,000 -13,000 -9,000 -13,000 -15,000 -13,000 -12,000 -4,000 -15,000 -11,000     
      total cash, cash equivalents and restricted cash per consolidated balance sheet
    		                             
      net decrease in cash, cash equivalents and restricted cash
    		   -48,319,000 -43,080,000                         
      derivative loss
    		                             
      net cash from settlement of derivative instruments
    		     2,978,000                        
      loss on debt extinguishment
    		                             
      interest expense
    		     23,503,000                        
      amortization of other non-current assets
    		         0 0 0 354,000 354,000 354,000 354,000 354,000 318,000 354,000 511,000 177,000         
      proceeds from sale of equity in subsidiaries
    		                             
      proceeds from sale of preferred stock
    		                             
      balance per consolidated balance sheet:
    		                             
      proceeds from sale of equity in intermediate holdings
    		                             
      proceeds from sale of rio bravo pipeline, llc
    		                             
      proceeds from sale of series c convertible preferred stock
    		         0 0 0 10,500,000 0 5,000,000               
      net increase in cash and cash equivalents
    		      405,847,000   -46,434,000 68,723,000 18,142,000 -3,194,000 -11,191,000 -3,852,000 1,305,000 16,682,000 -7,325,000 -7,646,000 -20,700,000 42,543,000 11,895,000 -702,000 -1,026,000 2,400,000 -30,711,000 15,034,000   
      cash and cash equivalents – beginning of period
    		      0 0 62,789,000 0 0 0 25,552,000 0 0 0 22,608,000 0 0 0 15,736,000 0 0 0 3,169,000 0 0 0 35,703,000 
      cash and cash equivalents – end of period
    		      405,847,000 -11,129,000 51,141,000 -46,434,000 68,723,000 18,142,000 22,358,000 -11,191,000 -3,852,000 1,305,000 39,290,000 -7,325,000 -7,646,000 -20,700,000 58,279,000 11,895,000 -702,000 -1,026,000 5,569,000 -30,711,000 15,034,000 -5,859,000 24,705,000 
      prepaid subscriptions
    		                             
      prepaid insurance
    		                             
      total prepaid expenses and other current assets
    		                             
      equity issuance costs
    		         -3,950,000 74,000   -151,000 -56,000 -7,000 -54,000     -198,000    -451,000    
      non-cash investing activities:
    		                             
      accounts payable for acquisition of property, plant and equipment
    		       6,994,000 72,000 -308,000 -307,000 438,000 339,000 -212,000 311,000 -61,000 79,000 -463,000 137,000 -2,999,000 3,341,000 10,387,000 6,000 94,000 864,000 -289,000 203,000 278,000 175,000 
      accrued liabilities for acquisition of property, plant and equipment
    		        15,826,000 8,142,000 2,677,000 388,000 839,000 -70,000 21,000 580,000 395,000 268,000 -147,000 -7,333,000 7,862,000 -12,813,000 14,258,000 -33,000 1,091,000 -2,042,000 -874,000 2,459,000 4,471,000 
      accrued liabilities for acquisition of other non-current assets
    		       317,000 140,000                     
      non-cash financing activities:
    		                             
      paid-in-kind dividends on convertible preferred stock
    		       6,735,000 6,686,000 6,485,000 6,232,000 5,755,000 5,735,000 5,262,000                
      accounts payable for debt and equity issuance costs
    		                             
      accrued liabilities for debt and equity issuance costs
    		                             
      prepaid expenses
    		        -421,000 146,000 -294,000 28,000 -194,000 48,000 -120,000 55,000 -169,000 130,000 78,000 201,000 -218,000 250,000 665,000 129,000 -471,000     
      net decrease in cash and cash equivalents
    		        -11,648,000                    -10,998,000 
      accounts payable for equity issuance costs
    		          3,879,000                   
      pipeline assets obtained in exchange for other non-current liabilities
    		             0 0 0 84,000 1,246,000            
      accretion of deemed dividends on series a convertible preferred stock
    		             16,000 16,000 15,000 16,000 15,000 16,000 21,000 76,000 193,000 285,000 488,000 551,000     
      accrued liabilities for equity issuance costs
    		            50,000 0                
      gain on common stock warrant liabilities
    		             170,000 -4,443,000 4,768,000 2,038,000    -8,339,000     -81,000    
      realized loss on investment securities
    		                             
      proceeds from sale of investment securities
    		                 0 0 0 61,972,000 28,500,000 12,500,000 19,000,000 17,000,000     
      purchase of investment securities
    		                 0 0 0 -188,000 -50,409,000 -303,000 -15,364,000 -439,000     
      proceeds from sale of rio bravo pipeline company, llc
    		                             
      proceeds from sale of rio bravo
    		                  0 0 15,000,000         
      paid-in-kind dividends on series a and series b convertible preferred stock
    		               3,862,000 3,862,000  3,600,000 3,494,000 3,430,000  2,839,000 2,461,000 2,491,000     
      net income (income) attributable to nextdecade corporation
    		                -3,658,000             
      adjustment to reconcile net income (income) to net cash from operating activities
    		                             
      proceeds from equity issuance
    		                24,500,000     50,000,000 0   0    
      (gain) loss on common stock warrant liabilities
    		                 -1,723,000 1,627,000           
      gain on investment securities
    		                             
      realized gain on investment securities
    		                 0 0 0 423,000 -99,000 -5,000 -23,000 -11,000     
      common stock issued in lieu of cash
    		                             
      paid-in-kind dividends on series a convertible preferred stock
    		                             
      dividends payable on series a and series b convertible preferred stock charged to additional paid-in capital
    		                        2,481,000     
      (gain) loss on investment securities
    		                     176,000 4,000 -96,000 -184,000     
      other current assets
    		                             
      amortization of right-of-use asset
    		                      274,000       
      loss on investment securities
    		                         86,000 3,000 3,000 22,000 
      issuance of note receivable
    		                             
      repayment of note receivable
    		                             
      cash received in reverse recapitalization
    		                             
      payment of convertible preferred stock cash dividends
    		                             
      net income
    		                          -10,680,000 -3,482,000 -16,200,000 
      prepaid expenses and other currents assets
    		                          391,000 87,000 -183,000 
      purchase of investments
    		                             
      accretion of deemed dividends series a convertible preferred stock
    		                             
      investments
    		                           -26,000 -24,000 
      accrued liability for deferred financing cost
    		                             
      impairment loss on capital projects
    		                             
      other assets
    		                             
      proceeds from equity issuances
    		                             
      dividends paid
    		                             
      cash, cash equivalents and restricted cash – beginning of year
    		                             
      cash, cash equivalents and restricted cash – end of year
    		                             
      balances per consolidated balance sheets:
    		                             
      cash flows from operating activities
    		                             
      adjustments to reconcile net income to net cash from operations:
    		                             
      interest earned on cash and securities in trust
    		                             
      cash flows from investing activities
    		                             
      withdrawal of trust funds to pay taxes
    		                             
      investment in cash, cash equivalents and securities in trust account
    		                             
      cash flows from financing activities
    		                             
      payment of offering costs
    		                             
      payment of deferred offering costs associated with initial public offering
    		                             
      note payable to stockholder
    		                             
      proceeds from sale of shares of common stock to initial stockholders
    		                             
      proceeds from public offering, net of offering costs
    		                             
      proceeds from insider units
    		                             
      cash and cash equivalents at beginning of period
    		                             
      cash and cash equivalents at end of period
    		                             
      supplemental disclosure of non-cash investing and financing activities
    		                             
      accrual of deferred underwriting fee
    		                             
      accrual of deferred offering costs
    		                             
      change in value of ordinary shares subject to possible conversion
    		                             
      proceeds from note payable, stockholder
    		                             
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.